Showing 18,201 - 18,220 results of 103,943 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 1.02s Refine Results
  1. 18201
  2. 18202
  3. 18203

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  4. 18204

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  5. 18205

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  6. 18206

    Conservation of superfamilies within five Asgard proteomes. by Steven Russum (10475294)

    Published 2021
    “…This figure was generated using Anvi’o [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref160" target="_blank">160</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref161" target="_blank">161</a>].…”
  7. 18207

    Social robot PIO (version 3.5). by Jun-Seo Lim (21161776)

    Published 2025
    “…The difference between the two groups was statistically significant (<i>t</i> = 3.94, <i>p</i><.001). Depression decreased -0.7±3.48 in the experimental group, from 5.9±4.74 before intervention to 5.2±4.65 after intervention, and decreased by -0.2±3.42, from 6.5±4.69 before intervention to 6.4±4.08 after intervention, in the control group, but the difference between the two groups was not statistically significant (<i>z</i> = -0.59, <i>p</i> =.557). …”
  8. 18208

    The 5hmrC modified mRNAs. by Badri Nath Singh (18004418)

    Published 2024
    “…<p><b>A.</b> Volcano plot of mRNAs that are increased (green) or decreased (red) relative to wildtype levels in <i>Tet</i><sup><i>null</i></sup> LBF preparations; <b>B.…”
  9. 18209
  10. 18210

    TMD-5 intrinsic Trp fluorescence assay. by Xiaohui Wang (19899)

    Published 2012
    “…(b), Pentamidine decreases Trp emission fluorescence intensity of TMD-5 in 150 µM C14 betaine and 50 mM HEPES (pH = 7.4) buffer in a dose-dependent manner. …”
  11. 18211

    Inhibition correlates with cellular PmV levels. by Luca Gambini (826027)

    Published 2015
    “…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
  12. 18212

    MCPyV circALTO can be translated. by Rong Yang (107028)

    Published 2021
    “…<p>(A) CircALTOs do not inhibit MCPyV miRNA function in vitro. 293 cells were transfected with <i>Renilla</i> luciferase reporter with a 300 nucleotide region complementary to the MCPyV miRNA and the indicated plasmids including a MCPyV-miRNA-M1 expression plasmid (derived from isolate MCV350), pCDNA3.1 control vector, pCDNA circALTO1 (pcircALTO1) or pCDNA circALTO2 (pcircALTO2) expression plasmid. …”
  13. 18213

    YorkU.forest.Oct5-2016 by Amrit Virdi (3130035)

    Published 2016
    “…</p><p><b>Abundance.woody.plants: </b>The total number of individual woody plants located within 0.5 meters of the 50m transect tape. A woody plant was defined as a tree that was over 1.5m in height. …”
  14. 18214

    V2G controls parameters [36]. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  15. 18215
  16. 18216

    Dynacortin facilitates polarization of chemotaxing cells-5 by Cathryn Kabacoff (40205)

    Published 2011
    “…A total of 2.5 M actin was present in each sample. …”
  17. 18217

    Plants components in five-flower remedy [24]. by Walaiporn Plirat (17775628)

    Published 2025
    “…This study aimed to explore the potential antimalarial and neuroprotective properties of the five-flower remedy (FFR), a traditional herbal formulation, in experimental cerebral malaria (ECM). …”
  18. 18218

    Five multi-target tracking evaluation indexes. by Wenshun Sheng (21485393)

    Published 2025
    “…<div><p>A real-time stable multi-target tracking method based on the enhanced You Only Look Once-v8 (YOLOv8) and the optimized Simple Online and Realtime Tracking with a Deep association metric (DeepSORT) for real-time stable multi-target tracking (S-YOFEO) is proposed to address the issue of target ID transformation and loss caused by the increase of practical background complexity. …”
  19. 18219

    5-HI stimulates GI motility in vivo. by Barbora Waclawiková (10024630)

    Published 2021
    “…<p><b>(A)</b> Graph shows effect of 5-HI on TGTT in WTG rats. …”
  20. 18220

    Ctcf and Smarca5 interact in AML cells. by Martina Dluhosova (519144)

    Published 2014
    “…D Smarca5 at ICR upon Ctcf knockdown. Occupancy of Smarca5 (lysates from 1A) by ChIP. …”